
Sign up to save your podcasts
Or


Dr Tiffany Richards from The University of Texas MD Anderson Cancer Center in Houston discusses the current and emerging role of bispecific antibodies in the treatment of multiple myeloma.
NCPD information and select publications here.
By Dr. Neil Love4.4
7272 ratings
Dr Tiffany Richards from The University of Texas MD Anderson Cancer Center in Houston discusses the current and emerging role of bispecific antibodies in the treatment of multiple myeloma.
NCPD information and select publications here.

320 Listeners

495 Listeners

66 Listeners

31 Listeners

14 Listeners

17 Listeners

12 Listeners

0 Listeners

115 Listeners

27 Listeners

291 Listeners

3,330 Listeners

197 Listeners

54 Listeners

57 Listeners

49 Listeners

189 Listeners

30 Listeners

0 Listeners